Neoplasm Metastasis

Enanta Presses Ahead with RSV Drug Zelicapavir Despite Missing Primary Endpoint in Phase IIb Trial

4 weeks ago talkbio0Tagged Clinical Trials, Congestive heart failure, COPD, development aspects, Elderly (population group), Enanta, Hospitalization, Neoplasm Metastasis, Phase II B Trial, primary endpoint, rates, Respiratory syncytial virus, United States Food and Drug Administration, Zelicapavir

Enanta Pharmaceuticals; RSV; zelicapavir; Phase IIb trial; primary endpoint miss; secondary endpoints; clinical trials; FDA Fast Track; elderly; COPD; congestive heart failure; hospitalization rates; future development

FDA Mandates Enhanced Safety Warnings for CAR-T Therapies Due to Secondary Cancer Risks

12 months ago talkbio0Tagged Autologous (qualifier value), Automobiles, BCMA, BCMA-directed, boxed, CAR-T therapy, Cautionary Warning, CD19-directed, Neoplasm Metastasis, T-cell immunotherapies, T-Lymphocyte, United States Food and Drug Administration

CAR-T therapy, secondary cancers, FDA boxed warnings, T-cell malignancies, BCMA-directed, CD19-directed, autologous CAR T-cell immunotherapies.

Abbott MitraClip Demonstrates Significant Benefits in Treating Functional, Leaky Heart Valves

1 year ago talkbio0Tagged abbott, Heart Valve Disease, MitraClip, Mitral Valve Insufficiency, Neoplasm Metastasis, Transcatheter mitral valve repair

MitraClip, Abbott, Heart Valve Disease, Secondary Mitral Regurgitation, Transcatheter Mitral Valve Repair